Crossmark

Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis

Crossref DOI link: https://doi.org/10.1186/s12885-019-6005-6

Published Online: 2019-08-09

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Yanxin

Wei, Jianping

Cai, Jing

Liu, Anwen
License Information

Text and Data Mining valid from 2019-08-09

Version of Record valid from 2019-08-09
More Information

Article History

Received: 18 January 2019

Accepted: 31 July 2019

First Online: 9 August 2019

Ethics approval and consent to participate

: The study was approved by the Ethics Committee of The Second Affiliated Hospital of Nanchang University. Written informed consents were obtained from all patients to perform radiotherapy or targeted therapy. Given that this is a retrospective study, we did not obtain written informed consents from all patients to participate in this study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below